Filed: 5/15/2024ACC: 0001214659-24-009128
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $1.26B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$1.26B
Total AUM (reported)
94.06M
Total Shares
Allocation by class
COMM$1.08B85.2%
ADRS$187.52M14.8%
Portfolio Concentration
Top 3$306.27M24.2%
4–10$431.38M34.1%
11–25$475.24M37.6%
Rest$52.01M4.1%
Top 3 weight
24.2%
Top 10 weight
58.3%
Voting Authority Distribution
Total shares with voting rights: 94.06M
Sole
Full voting authority
94.06M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
CG ONCOLOGY, INC.
SOLEShares3.57M
TypeSH
Market value$156.73M
12.39%
Sole
3.57M
Shared
0.00
None
0.00
DYNE THERAPEUTICS, INC
SOLEShares2.65M
TypeSH
Market value$75.24M
5.95%
Sole
2.65M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS, INC.
SOLEShares5.28M
TypeSH
Market value$74.30M
5.87%
Sole
5.28M
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares3.30M
TypeSH
Market value$71.18M
5.63%
Sole
3.30M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares1.60M
TypeSH
Market value$68.51M
5.42%
Sole
1.60M
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares2.20M
TypeSH
Market value$65.09M
5.15%
Sole
2.20M
Shared
0.00
None
0.00
INHIBRX,INC
SOLEShares1.75M
TypeSH
Market value$61.19M
4.84%
Sole
1.75M
Shared
0.00
None
0.00
KEROS THERAPEUTICS, INC.
SOLEShares879.34K
TypeSH
Market value$58.21M
4.60%
Sole
879.34K
Shared
0.00
None
0.00
GERON CORP
SOLEShares17.39M
TypeSH
Market value$57.39M
4.54%
Sole
17.39M
Shared
0.00
None
0.00
SAVARA INC.
SOLEShares10M
TypeSH
Market value$49.80M
3.94%
Sole
10M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX, INC.
SOLEShares5.32M
TypeSH
Market value$48.40M
3.83%
Sole
5.32M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares6.21M
TypeSH
Market value$41.76M
3.30%
Sole
6.21M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS, INC.
SOLEShares2.27M
TypeSH
Market value$41.45M
3.28%
Sole
2.27M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS, INC.
SOLEShares3.19M
TypeSH
Market value$41.12M
3.25%
Sole
3.19M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares149.28K
TypeSH
Market value$39.86M
3.15%
Sole
149.28K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares1.48M
TypeSH
Market value$33.84M
2.68%
Sole
1.48M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.99M
TypeSH
Market value$32.62M
2.58%
Sole
1.99M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares3.86M
TypeSH
Market value$32.10M
2.54%
Sole
3.86M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$30.37M
2.40%
Sole
1.42M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS, INC.
SOLEShares793.83K
TypeSH
Market value$28.86M
2.28%
Sole
793.83K
Shared
0.00
None
0.00
ADVERUM BIOTECHNOLOGIES, INC.
SOLEShares2.01M
TypeSH
Market value$28.40M
2.25%
Sole
2.01M
Shared
0.00
None
0.00
SOLENO THERAPEUTIVS, INC.
SOLEShares550K
TypeSH
Market value$23.54M
1.86%
Sole
550K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.04M
TypeSH
Market value$23.06M
1.82%
Sole
2.04M
Shared
0.00
None
0.00
Abivax SA
SOLEShares1.10M
TypeSH
Market value$15.73M
1.24%
Sole
1.10M
Shared
0.00
None
0.00
VISTAGEN THERAPEUTICS INC
SOLEShares2.68M
TypeSH
Market value$14.13M
1.12%
Sole
2.68M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY, INC.SOLE | COMM | 3.57M | SH | $156.73M 12.39% | 3.57M | 0.00 | 0.00 |
DYNE THERAPEUTICS, INCSOLE | COMM | 2.65M | SH | $75.24M 5.95% | 2.65M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS, INC.SOLE | COMM | 5.28M | SH | $74.30M 5.87% | 5.28M | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADRS | 3.30M | SH | $71.18M 5.63% | 3.30M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | ADRS | 1.60M | SH | $68.51M 5.42% | 1.60M | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COMM | 2.20M | SH | $65.09M 5.15% | 2.20M | 0.00 | 0.00 |
INHIBRX,INCSOLE | COMM | 1.75M | SH | $61.19M 4.84% | 1.75M | 0.00 | 0.00 |
KEROS THERAPEUTICS, INC.SOLE | COMM | 879.34K | SH | $58.21M 4.60% | 879.34K | 0.00 | 0.00 |
GERON CORPSOLE | COMM | 17.39M | SH | $57.39M 4.54% | 17.39M | 0.00 | 0.00 |
SAVARA INC.SOLE | COMM | 10M | SH | $49.80M 3.94% | 10M | 0.00 | 0.00 |
OCULAR THERAPEUTIX, INC.SOLE | COMM | 5.32M | SH | $48.40M 3.83% | 5.32M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 6.21M | SH | $41.76M 3.30% | 6.21M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS, INC.SOLE | COMM | 2.27M | SH | $41.45M 3.28% | 2.27M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS, INC.SOLE | COMM | 3.19M | SH | $41.12M 3.25% | 3.19M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COMM | 149.28K | SH | $39.86M 3.15% | 149.28K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COMM | 1.48M | SH | $33.84M 2.68% | 1.48M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 1.99M | SH | $32.62M 2.58% | 1.99M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | ADRS | 3.86M | SH | $32.10M 2.54% | 3.86M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $30.37M 2.40% | 1.42M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS, INC.SOLE | COMM | 793.83K | SH | $28.86M 2.28% | 793.83K | 0.00 | 0.00 |
ADVERUM BIOTECHNOLOGIES, INC.SOLE | COMM | 2.01M | SH | $28.40M 2.25% | 2.01M | 0.00 | 0.00 |
SOLENO THERAPEUTIVS, INC.SOLE | COMM | 550K | SH | $23.54M 1.86% | 550K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | COMM | 2.04M | SH | $23.06M 1.82% | 2.04M | 0.00 | 0.00 |
Abivax SASOLE | ADRS | 1.10M | SH | $15.73M 1.24% | 1.10M | 0.00 | 0.00 |
VISTAGEN THERAPEUTICS INCSOLE | COMM | 2.68M | SH | $14.13M 1.12% | 2.68M | 0.00 | 0.00 |
Page 1 of 2